Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 16, 2011


Former chief financial officer of Myriad Genetics, Jay Moyes, has been appointed to the board of directors at Integrated Diagnostics. After his tenure at Myriad, Moyes served as chief financial officer of XDx, a molecular diagnostic company. Currently, he is director and chair of the audit committees of both Osiris Therapeutics and BioCardia.

Former vice president of sales at Myriad, Mark Willig, has been named executive vice president of North American sales at Agendia. Willig has held a number of leadership positions within the healthcare industry, including general manager and chief commercial officer at Exiqon, vice president of global sales for Thermo Fisher's anatomic pathology business unit, executive vice president of sales and marketing at Specialty Labs, as well as 12 years in commercial roles at Abbott Diagnostics. He holds a BS from the University of Missouri.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.